ReviewBiochemical Society transactions2026
Escape from X-chromosome inactivation: from gene discovery to regulatory mechanisms.
Review in Biochemical Society transactions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Early in mammalian development, one of the two X chromosomes in female embryos is largely silenced through X-chromosome inactivation (XCI). Although essential for dosage compensation, XCI is incomplete, with ∼5%-20% of X-linked genes escaping silencing. Escape from XCI represents an important source of sex-biased gene expression and has been increasingly linked to sex differences in development and disease susceptibility. Yet, how a subset of X-linked genes bypass XCI remains poorly understood. Here, we discuss the studies that have revealed the prevalence and variability of XCI escape across genes, tissues, and individuals in both humans and mice. We then summarize current insights into the molecular features and regulatory mechanisms associated with XCI escape, highlighting key questions that remain to be addressed to understand how X-linked gene dosage is regulated and how it contributes to sex-biased biology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.